Turnstone Biologics, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Ottawa Canada (2015)

Organization Overview

First Clinical Trial
2016
NCT02879760
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Turnstone Biologics | Turnstone Biologics, Corp. | Turnstone Biologics, Inc.